NCT02643641View on ClinicalTrials.gov

Effect of Different Pre-seasonal BM32 Dosings on the Induction of a Protective Immune Response

PHASE2CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

January 31, 2017

Conditions
Hypersensitivity
Interventions
BIOLOGICAL

BM32

BM32 is a mixture of 4 different recombinant proteins directed at the major grass pollen allergens, adsorbed on aluminum hydroxide

BIOLOGICAL

Placebo

Placebo contains aluminum hydroxide only

Trial Locations (1)

1150

Vienna Challenge Chamber, Vienna

Sponsors

Lead Sponsor

Biomay AG
All Listed Sponsors
lead

Biomay AG

INDUSTRY

NCT02643641 - Effect of Different Pre-seasonal BM32 Dosings on the Induction of a Protective Immune Response | Biotech Hunter | Biotech Hunter